Whilst capturing and recording valid and accurate data is important for any company in any sector, it’s essential for businesses operating in the Research and Development (R&D) industry. Recording and working with data that could potentially contribute to life-changing discoveries means that there really isn’t any room for unreliable...
The amount of data that’s generated ever day staggering. According to an article published in Forbes magazine: “The volume of data is exploding. More data has been created in the past two years than in the entire previous history of the human race.” With that in mind then, it...
According to research revealed earlier this year, “the global LIMS (Laboratory Information Management Systems) market is expected to reach USD $1,155.67 million by 2025, from USD $650.7 million in 2017.” This predicts a CAGR (Compound Annual Growth Rate) of 7.7% in the forecast period. Technology is undoubtedly growing at...
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In his final blog, Scott looks at whether a single platform could be the way forward for your organization. Informatics platforms have measurable benefits including fast time-to-value, lower up-front costs, and capabilities...
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In this second blog, Scott examines the benefits of adopting an integrated platform. It doesn’t matter if you are a large pharma company or a small biotech, everyone needs to manage their...
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharmaceutical drug development. In this first blog, Scott examines the market challenges and obstacles businesses face when trying to get to market faster. A recent report from PwC, “From Vision to Decision Pharma...
Following Fierce Biotech’s story revealing $10 million has been raised to bring a $4,000 lab robot into the mainstream, we delve into the driving factors that are required to make process and system automation commonplace in the pharma and biotech R&D sector. Imagine a world with no need for...
“But I want to highlight one initiative, in particular: our efforts to build a knowledge management platform as part of our drug and medical device review programs.” – Scott Gottlieb, FDA Commissioner In light of Scott Gottlieb’s announcement before Congress that the FDA is seeking funding for an electronic-based...
The Biologics sector is continuing to grow at an accelerated pace – and it’s showing no signs of slowing down. Just recently, Pharmaceutical Product Development, LLC (PPD) announced the expansion of its GMP analytical laboratory, nearly doubling its analytics testing capacity. According to Jon Denissen, the company’s Senior Vice...
Recently, Pharma IQ compiled a list of the top ten CMOs in drug discovery for 2018. The piece got us thinking… The CMO market is on the rise, and predictions estimate it will reach US$205.104 billion by 2021. This phenomenal rise can be attributed to rising medicine prices and...
